Indivior Pharmaceuticals, Inc.
INDV
DELAYED 1 MONTH
15 insider filings · Latest: Jun 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jun 10 10:04 AM | Ryan PreblickChief Financial Officer | Sale | 36,000 | $37.70 | $1.4M | 284,751(D) | View → |
| Mar 13, 2026 | Mar 13 8:25 PM | Barbara RyanDirector | Purchase | 8 | $31.09 | $249 | 5,724(D) | View → |
| Mar 6, 2026 | Mar 11 1:54 PM | Stuart A KingsleyDirector | Purchase | 940 | $31.87 | $30.0K | 5,582(D) | View → |
| Mar 9, 2026 | Mar 11 12:12 PM | Barbara RyanDirector | Purchase | 31 | $32.56 | $1.0K | 5,716(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 9:00 PM | Woodrow D AndersonChief Accounting Officer | Option Exercise | 29,921 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:00 PM | Ryan PreblickChief Financial Officer | Option Exercise | 113,510 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 8:59 PM | Jeffrey W BurrisChief Legal Officer | Option Exercise | 104,300 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 8:59 PM | Christian HeidbrederChief Scientific Officer | Option Exercise | 132,565 | — | 0(D) | View → |